E Fund Management’s NovaBridge Biosciences American Depositary Shares NBP Stock Holding History

E Fund Management’s Portfolio NBP Stock Details NBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-62,962	Closed	-$263K	–	345
2022 Q4	$263K	Sell	62,962 -39,195	-38%	-$148K	0.02%	248
2022 Q3	$410K	Sell	102,157 -310,000	-75%	-$2.35M	0.04%	177
2022 Q2	$4.66M	Sell	412,157 -22,666	-5%	-$272K	0.42%	36
2022 Q1	$7.01M	Buy	434,823 +46,050	+12%	+$1.18M	0.23%	26
2021 Q4	$18.4M	Buy	388,773 +45,126	+13%	+$2.71M	0.65%	14
2021 Q3	$24.9M	Buy	+343,647	New	+$24.9M	1.04%	13
2021 Q1	$17.2M	Buy	+355,865	New	+$19.3M	1.42%	17

Other funds holding NBP

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

E Fund Management's NBP Position: Q1 2023 in Review

E Fund Management sold out of NovaBridge Biosciences American Depositary Shares (NBP) in Q1 2023, closing a stake of 62,962 shares — an estimated $263K sold.

E Fund Management first reported a position in NBP in Q1 2021 and held it in 7 quarters. The position peaked at $24.9M in Q3 2021. 53 funds tracked by Wall St. Rank hold NBP as of Q1 2023.

E Fund Management reported no remaining NovaBridge Biosciences American Depositary Shares position as of Q1 2023 after selling out during the quarter.
E Fund Management sold 62,962 NovaBridge Biosciences American Depositary Shares shares in Q1 2023, an estimated $263K.
E Fund Management first reported a position in NovaBridge Biosciences American Depositary Shares in Q1 2021 and held it in 7 quarters.
E Fund Management's NovaBridge Biosciences American Depositary Shares position peaked at $24.9M in Q3 2021.
53 funds tracked by Wall St. Rank held NovaBridge Biosciences American Depositary Shares as of Q1 2023.

Based on E Fund Management's 13F filing for Q1 2023, filed 11 May 2023.